🇺🇸 FDA
Patent

US 8846859

Compositions and methods of use of targeting peptides against placenta and adipose tissues

granted A61KA61K31/70A61K38/08

Quick answer

US patent 8846859 (Compositions and methods of use of targeting peptides against placenta and adipose tissues) held by The Board of Regents of the University of Texas System expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/70, A61K38/08, A61P, A61P3/04